On June 8, 2022, Senti Biosciences, Inc. closed the transaction. The company has amended the terms of the transaction and received gross proceeds of $50.6 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.361 USD | +24.48% | +3.24% | -56.06% |
1st Jan change | Capi. | |
---|---|---|
-56.06% | 14.17M | |
-2.69% | 102B | |
+1.90% | 96.29B | |
+1.83% | 22.18B | |
-15.37% | 21.2B | |
-8.84% | 18.31B | |
-38.74% | 17.38B | |
-13.62% | 16.36B | |
+5.76% | 13.97B | |
+33.12% | 12.17B |
- Stock Market
- Equities
- SNTI Stock
- News Senti Biosciences, Inc.
- Senti Biosciences, Inc. announced that it has received $50.6 million in funding from a group of investors